Diseases, Conditions, Syndromes

'Mop up' malaria vaccine advances to trials in people

University of Florida researcher Rhoel Dinglasan, Ph.D., was awarded $6 million today by the Global Health Innovative Technology Fund to test a new malaria vaccine in people. The process leading to a phase 1 clinical trial ...

Diseases, Conditions, Syndromes

Real-world proof that Pfizer, Moderna vaccines slash COVID infections

(HealthDay)—The two-dose mRNA vaccines from Pfizer and Moderna have proven to be potent weapons against COVID-19 infection among health care workers, first responders and essential workers in the real world, a new U.S. ...

Pediatrics

Pfizer begins COVID vaccine trial in young children

Pfizer said Thursday it had begun clinical trials for its COVID vaccine in children under the age of eleven, an early sign of the next stage of the global immunization campaign.

Medical research

Genomic sieve analysis can inform SARS-CoV-2 vaccine development

As concern has grown over COVID-19 variants and their implications for how well COVID-19 vaccines will protect against the virus, researchers have proposed a method to examine instances of SARS-COV-2 infections in people ...

HIV & AIDS

HIV vaccine candidate's mysteries unlocked 20 years later

About two decades after first devising a new kind of vaccine, Oregon Health & Science University researchers are unlocking why it stops and ultimately clears the monkey form of HIV, called SIV, in about half of nonhuman primates—and ...

page 37 from 40